Literature DB >> 23393183

Coronary artery disease detected by multislice computed tomography in patients after long-term cure of Cushing's syndrome.

María-José Barahona1, Eugenia Resmini, David Viladés, Guillem Pons-Lladó, Rubén Leta, Teresa Puig, Susan M Webb.   

Abstract

OBJECTIVE: Increased cardiovascular risk persists in Cushing's syndrome (CS), despite remission of hypercortisolism. The aim of this study was to evaluate the prevalence of coronary artery disease in patients after long-term cure of CS.
METHODS: Cardiac multidetector computed tomography was performed in 29 cured CS patients (5 men, 21 of pituitary origin, 50 ± 13 y, mean time of "cure" 11 ± 6 y), using 64-slice Toshiba Aquilion systems (Toshiba Medical Systems, Otawara, Japan). Noncontrast acquisitions were performed to detect coronary calcifications and, after injection of an iodinated contrast agent, for coronary angiography. Calcium was quantified by the Agatston score. Cured patients were compared with 48 gender-matched and age-matched healthy controls.
RESULTS: Cured CS patients had more hypertension and smoked less than controls (P < .05). The prevalence of coronary calcifications (31% vs 21%) and noncalcified plaques (20% vs 7.8%) tended to be higher in cured CS patients than controls. When only women were analyzed (24 CS and 34 controls), more abnormal multidetector computed tomography results were found (42% vs 18%; P < .05). When patients and controls in the youngest tertile (<45 y) were compared, cured CS patients had significantly more noncalcified plaques than controls (30% vs 0%, P = .01); this difference persisted when hypopituitary or dyslipidemic CS patients were excluded.
CONCLUSION: Despite long-term biochemical "cure" of CS, patients exhibit more coronary artery disease, especially in women and in those aged <45 years, in comparison to healthy matched controls.

Entities:  

Mesh:

Year:  2013        PMID: 23393183     DOI: 10.1210/jc.2012-3547

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

Review 1.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

Review 2.  Impairment of Arterial Compliance in Cushing's Syndrome.

Authors:  Pier Paolo Bassareo; Angela Maria Zedda; Giuseppe Mercuro
Journal:  Eur Endocrinol       Date:  2014-08-28

3.  The degree of urinary hypercortisolism is not correlated with the severity of cushing's syndrome.

Authors:  Valentina Guarnotta; Marco C Amato; Rosario Pivonello; Giorgio Arnaldi; Alessandro Ciresi; Laura Trementino; Roberto Citarrella; Davide Iacuaniello; Grazia Michetti; Chiara Simeoli; Annamaria Colao; Carla Giordano
Journal:  Endocrine       Date:  2016-03-10       Impact factor: 3.633

Review 4.  Clinical and biochemical manifestations of Cushing's.

Authors:  Georgia Ntali; Ashley Grossman; Niki Karavitaki
Journal:  Pituitary       Date:  2015-04       Impact factor: 4.107

5.  Soluble TNFα-receptor 1 as a predictor of coronary calcifications in patients after long-term cure of Cushing's syndrome.

Authors:  María-José Barahona; Eugenia Resmini; David Viladés; José-Manuel Fernández-Real; Wifredo Ricart; José-María Moreno-Navarrete; Guillem Pons-Lladó; Rubén Leta; Susan M Webb
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

Review 6.  Cardiovascular risk and mortality in patients with active and treated hypercortisolism.

Authors:  Dingfeng Li; Omar M El Kawkgi; Andres F Henriquez; Irina Bancos
Journal:  Gland Surg       Date:  2020-02

Review 7.  Cushing's syndrome: epidemiology and developments in disease management.

Authors:  Susmeeta T Sharma; Lynnette K Nieman; Richard A Feelders
Journal:  Clin Epidemiol       Date:  2015-04-17       Impact factor: 4.790

8.  Decreased Aerobic Exercise Capacity After Long-Term Remission From Cushing Syndrome: Exploration of Mechanisms.

Authors:  Sean H P P Roerink; Matthew S Cocks; Margreet A E M Wagenmakers; Raffaella P Rodighiero; Juliette A Strauss; Sam O Shepherd; Theo S Plantinga; Dick H J Thijssen; Maria T E Hopman; Alberto M Pereira; Jan W Smit; Anton J M Wagenmakers; Romana T Netea-Maier; Ad R M M Hermus
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

9.  Rationale and design of the cardiovascular status in patients with endogenous cortisol excess study (CV-CORT-EX): a prospective non-interventional follow-up study.

Authors:  Kristina Ehrlich; Caroline Morbach; Theresa Reiter; Peter Ulrich Heuschmann; Anke Hannemann; Martin Fassnacht; Stefan Störk; Stefanie Hahner; Timo Deutschbein
Journal:  BMC Endocr Disord       Date:  2021-01-08       Impact factor: 2.763

Review 10.  Cardiovascular complications of Cushings syndrome: Impact on morbidity and mortality.

Authors:  Richard N Clayton
Journal:  J Neuroendocrinol       Date:  2022-06-28       Impact factor: 3.870

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.